Form 4 for NKTR NEKTAR THERAPEUTICS
Accepted 2021-09-10 00:00:00 ET · period of report 2021-09-08 · accession 0001209191-21-055543 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-10 | 2021-09-08+ | NKTR | CHESS ROBERT | Dir | S - Sale+OE | $16.01 | -18.3K | 274.3K | -6% | -$292.7K |
| DM | 2021-09-10 | 2021-09-08+ | NKTR | CHESS ROBERT | Dir | M - OptEx | $13.80 | +18.3K | 282.3K | +7% | +$252.3K |
| DM | 2021-09-10 | 2021-09-08+ | NKTR | CHESS ROBERT | Dir | M - OptEx | $0.00 | -18.3K | 10.3K | -64% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-09 | S | D | 10,279 | $16.02 | 274,273 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on September 18, 2021. (F3) This transaction was executed in multiple trades at prices ranging from $15.76 to $16.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. |
| 2 | Common | Common Stock | 2021-09-09 | M | A | 10,279 | $13.80 | 284,552 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on September 18, 2021. |
| 3 | Common | Common Stock | 2021-09-08 | S | D | 8,000 | $16.00 | 274,273 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on September 18, 2021. (F2) This transaction was executed in multiple trades at prices ranging from $15.85 to $16.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. |
| 4 | Common | Common Stock | 2021-09-08 | M | A | 8,000 | $13.80 | 282,273 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on September 18, 2021. |
| 5 | Derivative | Common Stock | 2021-09-09 | M | D | 10,279 | $0.00 | 0 | D | $13.80 · 2014-09-30 to 2021-09-18 | 10,279 Common Stock | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on September 18, 2021. |
| 6 | Derivative | Common Stock | 2021-09-08 | M | D | 8,000 | $0.00 | 10,279 | D | $13.80 · 2014-09-30 to 2021-09-18 | 8,000 Common Stock | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on September 18, 2021. |